Wanner C - Search Results

1

Inflammation and cardiovascular risk in dialysis patients.

Wanner C, Zimmermann J, Schwedler S, Metzger T. Wanner C, et al. Kidney Int Suppl. 2002 May;(80):99-102. doi: 10.1046/j.1523-1755.61.s80.18.x. Kidney Int Suppl. 2002. PMID: 11982822 Free article.

2

Smoking as a risk factor for end-stage renal failure in men with primary renal disease.

Orth SR, Stöckmann A, Conradt C, Ritz E, Ferro M, Kreusser W, Piccoli G, Rambausek M, Roccatello D, Schäfer K, Sieberth HG, Wanner C, Watschinger B, Zucchelli P. Orth SR, et al. Among authors: wanner c. Kidney Int. 1998 Sep;54(3):926-31. doi: 10.1046/j.1523-1755.1998.00067.x. Kidney Int. 1998. PMID: 9734618 Free article.

3

L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation.

Schramm L, La M, Heidbreder E, Hecker M, Beckman JS, Lopau K, Zimmermann J, Rendl J, Reiners C, Winderl S, Wanner C, Schmidt HH. Schramm L, et al. Among authors: wanner c. Kidney Int. 2002 Apr;61(4):1423-32. doi: 10.1046/j.1523-1755.2002.00268.x. Kidney Int. 2002. PMID: 11918749 Free article. Clinical Trial.

4

Advanced glycation end products and mortality in hemodialysis patients.

Schwedler SB, Metzger T, Schinzel R, Wanner C. Schwedler SB, et al. Among authors: wanner c. Kidney Int. 2002 Jul;62(1):301-10. doi: 10.1046/j.1523-1755.2002.00423.x. Kidney Int. 2002. PMID: 12081592 Free article.

5

C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.

Wanner C, Metzger T. Wanner C, et al. Nephrol Dial Transplant. 2002;17 Suppl 8:29-32; discussion 39-40. doi: 10.1093/ndt/17.suppl_8.29. Nephrol Dial Transplant. 2002. PMID: 12147774 Review.

6

Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?

Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C. Stenvinkel P, et al. Among authors: wanner c. Kidney Int. 2002 Nov;62(5):1791-8. doi: 10.1046/j.1523-1755.2002.00637.x. Kidney Int. 2002. PMID: 12371981 Free article.

7

Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patients.

Wanner C, Krane V. Wanner C, et al. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S72-5. doi: 10.1053/ajkd.2003.50089. Am J Kidney Dis. 2003. PMID: 12612957 Review.

8

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J. Ketteler M, et al. Among authors: wanner c. Lancet. 2003 Mar 8;361(9360):827-33. doi: 10.1016/S0140-6736(03)12710-9. Lancet. 2003. PMID: 12642050

9

Endothelial dysfunction and inflammation: what is the link?

Galle J, Quaschning T, Seibold S, Wanner C. Galle J, et al. Among authors: wanner c. Kidney Int Suppl. 2003 May;(84):S45-9. doi: 10.1046/j.1523-1755.63.s84.12.x. Kidney Int Suppl. 2003. PMID: 12694307 Free article. Review.

10

Vasopeptidase inhibition: a new treatment approach for endothelial dysfunction.

Quaschning T, Galle J, Wanner C. Quaschning T, et al. Among authors: wanner c. Kidney Int Suppl. 2003 May;(84):S54-7. doi: 10.1046/j.1523-1755.63.s84.35.x. Kidney Int Suppl. 2003. PMID: 12694309 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,047 results

Search Page

Filters